{"id":"W1480633459","doi":"10.1016/s0065-3233(01)56004-0","title":"Cyclooxygenase-2 inhibitors","year":2001,"lang":"en","type":"review","venue":"Advances in protein chemistry","topic":"Inflammatory mediators and NSAID effects","field":"Medicine","cited_by":9,"is_retracted":false,"has_abstract":false,"ca_institutions":"Merck Canada Inc. (Canada)","funders":"","keywords":"Rofecoxib; Cyclooxygenase; Antiinflammatory drug; Nonsteroidal; Adverse effect; Prostaglandin; Pharmacology; Drug; Prostaglandin-Endoperoxide Synthase; Drug discovery; Medicine; Arachidonic acid; Chemistry; Enzyme; Biochemistry; Internal medicine","routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false,"invisible_to_affiliation_only":false},"retraction":null,"screen":null,"direct_labels":[],"prediction":{"model_version":"codex-gemma-dda1882f352a","candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.0002772984,0.0006013245,0.001859345,0.000103997,0.00004205437,0.00001384547,0.0002236737,0.0006617825,0.0002870554],"category_scores_gemma":[0.000366697,0.0004924092,0.0004386621,0.0005500019,0.0001182827,0.0001269788,0.00008030726,0.001032929,0.0001057928],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.0003424942,"about_ca_system_score_gemma":0.0005193846,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.000003103835,"about_ca_topic_score_gemma":0.000003030758,"domain_scores_codex":[0.9975982,0.00005655649,0.0008160112,0.0006403942,0.0003632114,0.0005255843],"domain_scores_gemma":[0.9986037,0.0001154645,0.0003695577,0.0006453138,0.00004035215,0.0002255909],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"design_other","study_design_gemma":"not_applicable","study_design_scores_codex":[0.00002041106,0.00008528996,0.00001806715,0.1131494,0.00003347368,0.001013055,0.000009634548,3.677955e-7,0.000141334,0.000005704612,0.0001169739,0.8854063],"study_design_scores_gemma":[0.0004784369,0.00003289346,2.990172e-7,0.04909594,0.0001642993,0.0002927438,0.000008697768,8.597755e-7,0.003893875,0.00004912104,0.945549,0.0004338265],"study_design_candidate":"not_applicable","study_design_consensus":null,"genre_codex":"review","genre_gemma":"review","genre_scores_codex":[0.000266546,0.9851041,0.000003932539,0.00001200334,0.0002613839,0.001658416,0.00001214168,0.0001025937,0.01257891],"genre_scores_gemma":[0.00004056604,0.9947434,0.0002389428,0.00001993335,0.001225906,0.001020752,0.0001424754,0.0001051162,0.00246289],"genre_candidate":"review","genre_consensus":"review","teacher_disagreement_score":0.945432,"threshold_uncertainty_score":0.9997528,"prediction_status":"machine_predicted_unvalidated"},"machine_scores":{"provisional":true,"baseline":true,"maturity_gate_passed":false,"score_opus":0.01354160633394709,"score_gpt":0.32431309780936,"score_spread":0.3107714914754129,"validation_status":"score_only:v0-immature-baseline","note":"Baseline scores from an immature model (maturity gate not passed). Scores rank; they never assert a category."}}